Peptide Therapy
TB-500: THYMOSIN BETA-4
A tissue repair peptide that promotes healing, reduces inflammation, and accelerates recovery from injury. What it does, how it works, and what the evidence actually says.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · Published March 24, 2026
Book Consultation
WHAT IS TB-500?
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide found in virtually all human and animal cells. It's one of the most abundant peptides in the body, present in blood platelets, wound fluid, and most tissues. TB-500 is the synthetic version used therapeutically.
First isolated from the thymus gland in the 1960s when Dr. Allan Goldstein and his team at the Albert Einstein College of Medicine began characterizing the thymosin family of peptides. The thymus gland plays a critical role in immune system development, and thymosin beta-4 was identified as one of its key signaling molecules.
What makes TB-500 clinically interesting is its role in cell migration, tissue repair, and inflammation regulation. When you're injured, thymosin beta-4 is one of the first peptides released at the wound site. It helps cells move to where they're needed and supports the formation of new blood vessels and tissue. TB-500 mimics this natural healing signal.
RegeneRx Biopharmaceuticals developed TB-500 through early clinical stages, including Phase II trials for wound healing and dry eye syndrome. The compound showed consistent promise, but the company couldn't secure funding to push through Phase III — a common problem with peptides that can't be strongly patented.
Key distinction: Thymosin beta-4 (TB-4) is the naturally occurring peptide. TB-500 is the synthetic version. They're functionally identical. You'll see both names used interchangeably — they refer to the same compound.
BENEFITS OF TB-500
TB-500 has been studied primarily for tissue repair and recovery. Here's what the available evidence supports:
Wound Healing & Tissue Repair
TB-500's primary studied application. Phase II clinical trials showed accelerated wound closure in chronic and acute skin wounds. It promotes cell migration to injury sites and supports the formation of new tissue — the core mechanism behind its healing effects.
Muscle Recovery
Animal studies show TB-500 accelerates muscle fiber repair after injury. It promotes satellite cell activation — the stem-cell-like cells responsible for muscle regeneration. Athletes and active individuals have used it for faster recovery from strains and overuse injuries.
Reduced Inflammation
TB-500 downregulates pro-inflammatory cytokines and modulates the immune response at injury sites. This reduces excessive inflammation without suppressing the immune system entirely — it shifts the balance from destructive inflammation toward constructive repair.
Joint & Tendon Health
Tendons and ligaments have poor blood supply, which is why they heal slowly. TB-500 promotes angiogenesis (new blood vessel formation) and cell migration into these avascular tissues, potentially accelerating recovery from tendinopathies and ligament injuries.
Cardiac Repair (Early Research)
Animal models have shown TB-500 can promote cardiac tissue repair after myocardial infarction, activating cardiac progenitor cells and reducing scar tissue formation. This is preclinical — not something used therapeutically yet — but it's a significant area of ongoing research.
Hair Regrowth (Limited Evidence)
Some anecdotal reports and limited evidence suggest TB-500 may support hair regrowth, likely through its effects on blood vessel formation and stem cell activation in hair follicles. This is not a primary indication and the evidence is not strong enough to recommend it specifically for hair loss.
Important context: TB-500's strongest evidence comes from Phase II clinical trials for wound healing and dry eye, plus extensive animal model research. Most of the optimization-focused evidence (muscle recovery, tendon repair, joint health) is extrapolated from animal studies and clinical observation — not randomized human trials. That doesn't mean it doesn't work. It means the evidence base has the same gap that most peptides face: promising early data, underfunded clinical pipelines.
HOW TB-500 WORKS
TB-500's mechanism of action centers on one protein: actin. Understanding this explains nearly everything about how the peptide works.
Actin is one of the most abundant proteins in your cells. It forms the structural scaffolding (cytoskeleton) that gives cells their shape and enables them to move. When tissue is damaged, cells need to migrate to the injury site, divide, and rebuild. All of this requires actin.
Upregulates Actin
TB-500 sequesters G-actin (the monomeric form) and promotes its polymerization into F-actin (the filamentous form that cells use for structure and movement). This is the foundational mechanism — by increasing the availability and organization of actin, TB-500 enables cells to migrate to where they're needed and build new tissue faster.
Promotes Angiogenesis
TB-500 stimulates the formation of new blood vessels from existing vasculature. This is critical for healing — injured tissue needs oxygen and nutrients delivered via blood supply. Tendons, ligaments, and chronic wounds often lack adequate blood flow, which is why they heal slowly. TB-500 addresses this directly.
Reduces Inflammatory Cytokines
TB-500 decreases the production of pro-inflammatory mediators like IL-1, TNF-alpha, and other cytokines that drive excessive inflammation at injury sites. Inflammation is necessary for healing initiation, but chronic or excessive inflammation delays repair. TB-500 helps shift the balance toward resolution and regeneration.
Supports Stem Cell Maturation
Research shows TB-500 activates satellite cells in muscle tissue and cardiac progenitor cells in heart tissue — stem-cell-like populations responsible for tissue regeneration. It promotes their differentiation into functional tissue cells, supporting the body's own repair machinery.
Modulates Immune Response
As a thymosin peptide originally isolated from the thymus gland, TB-500 has immunomodulatory properties. It doesn't suppress the immune system — it helps regulate it. This is relevant for conditions where immune dysfunction contributes to tissue damage or delayed healing.
DOSING & ADMINISTRATION
TB-500 is administered via subcutaneous injection. Dosing follows a loading-then-maintenance pattern designed to build tissue levels quickly, then sustain them.
Loading Phase
Dose: 2.5mg twice per week
Duration: 4-6 weeks
Purpose: Saturate tissue levels to kickstart the repair process
Supply: ~2 vials per month
Maintenance Phase
Dose: 2.5mg once per week or every 2 weeks
Duration: As needed based on response
Purpose: Sustain repair and prevent regression
Supply: ~1 vial per month
Administration Details
Route: Subcutaneous injection (belly fat or thigh)
Vial: 3ml vial at 3.33mg/ml concentration (9.99mg total per vial)
Storage: Ships overnight refrigerated. Store in refrigerator (2-8°C) after reconstitution.
Typical cycle: 6-12 weeks total (loading + maintenance), then reassess
Note: These are general protocols. Your provider will adjust dosing based on the condition being treated, your body weight, response to therapy, and whether TB-500 is being combined with other peptides. Don't self-dose based on internet protocols.
SIDE EFFECTS & RISKS
TB-500 has a favorable safety profile in published research. Clinical trials for wound healing reported no serious adverse events. Here's what to know:
Common (mild): Injection site irritation — redness, minor swelling, or tenderness at the injection site. This is typical of any subcutaneous injection and usually resolves within a day.
Less common: Mild headache, temporary lethargy, and occasional head rush shortly after injection. These effects are typically brief and self-resolving.
Clinical trial data: RegeneRx's Phase II trials for wound healing and Sosne's dry eye studies showed a favorable safety profile with no serious adverse events attributed to the compound. The most common complaints were mild and transient.
The biggest risk isn't the peptide — it's the source. The same principle applies to TB-500 as to BPC-157 and every other peptide: pharmaceutical-grade compounds prescribed at proper doses have a manageable risk profile. The serious risks come from unregulated "research chemical" products with unknown purity, wrong concentrations, and potential contamination. If you're injecting something, you need to know exactly what's in the vial. Read more about the research chemical problem.
WHO IS TB-500 FOR?
Good Candidates
Athletes with muscle injuries — strains, tears, and overuse injuries where accelerated repair is the goal.
Chronic tendon/ligament issues — tendinopathies, partial tears, and chronic joint problems that haven't responded to conventional treatment.
Post-surgical recovery — supporting tissue repair after orthopedic or soft tissue procedures.
Chronic inflammation — systemic or localized inflammatory conditions that impair healing and function.
Slow-healing wounds — the original clinical indication. Useful for wounds that aren't responding to standard care.
Who Should Avoid TB-500
Pregnant or nursing women — insufficient safety data in pregnancy. Not recommended.
Active cancer — TB-500 promotes cell migration and angiogenesis. These are beneficial for healing but could theoretically support tumor growth. Anyone with active or recent cancer should not use TB-500.
Immunocompromised individuals — TB-500 modulates immune function. In patients with already compromised immunity, this modulation could have unpredictable effects. Medical screening is essential.
Bottom line: TB-500 is best suited for otherwise healthy individuals dealing with injury, chronic pain, or slow recovery. A medical evaluation before starting is non-negotiable — not because the peptide is dangerous, but because the conditions it treats need proper diagnosis first.
HOW TO GET TB-500
TB-500 (thymosin beta-4) was removed from 503B compounding eligibility by the FDA in 2024. This means large outsourcing facilities cannot produce it in bulk without individual prescriptions. However, the regulatory picture has nuance:
503A compounding pharmacies — traditional pharmacies that compound medications on a patient-specific basis with a valid prescription from a licensed provider — operate under different rules than 503B outsourcing facilities. The regulatory landscape for TB-500 through 503A pharmacies continues to evolve.
At Moonshot Medical, we work with licensed 503A compounding pharmacies that produce pharmaceutical-grade compounds under strict quality standards. Every vial is tested for identity, purity, potency, and sterility. This is fundamentally different from "research chemical" products sold online.
The process: Consultation with a medical provider → evaluation and screening → prescription to a licensed compounding pharmacy → compound shipped directly to you with dosing instructions. The pharmacy requires a valid prescription — you can't buy it over the counter or online legally for human use.
COST AT MOONSHOT
Straightforward pricing. No hidden fees.
$250/mo
TB-500 therapy at Moonshot Medical in Park Ridge, IL
Included
Pharmaceutical-grade compound, medical oversight, and customized dosing protocol
Not Covered
Insurance does not typically cover peptide therapy — cash-pay service
Requires an initial consultation to evaluate whether TB-500 is appropriate for your condition. We don't prescribe peptides without a medical assessment — that's not caution, that's competent medicine.
View all peptide services at Moonshot Medical →TB-500 FAQ
What is TB-500?
TB-500 is the synthetic version of thymosin beta-4, a naturally occurring 43-amino-acid peptide found in virtually all human and animal cells. It plays a key role in tissue repair, cell migration, and inflammation regulation. First isolated from the thymus gland, it has been studied since the 1960s for its healing properties.
Is TB-500 legal?
TB-500 (thymosin beta-4) was removed from 503B compounding eligibility by the FDA in 2024. It cannot be legally compounded by 503B outsourcing facilities. However, 503A compounding pharmacies may still compound it on a patient-specific basis with a valid prescription. The regulatory landscape is evolving — consult a medical provider familiar with current peptide regulations for the latest status.
How long does TB-500 take to work?
Most patients notice improvement in 2-4 weeks, particularly reduced pain and improved mobility at injury sites. Full benefit typically develops over 6-12 weeks of consistent use. Response varies based on the type and severity of the condition being treated, as well as individual healing capacity.
What's the difference between TB-500 and BPC-157?
Different mechanisms, complementary effects. TB-500 promotes tissue repair primarily by upregulating actin and enhancing cell migration to injury sites. BPC-157 works through growth factor upregulation and angiogenesis (new blood vessel formation). They target healing through different pathways, which is why they're often combined for synergistic effect — a combination sometimes called the Wolverine Blend.
How much does TB-500 cost?
$250 per month at Moonshot Medical in Park Ridge, IL. This includes the pharmaceutical-grade compound, medical oversight, and a customized dosing protocol. During the loading phase you'll use approximately 2 vials per month; maintenance drops to about 1 vial per month.
Can TB-500 help with hair loss?
There is some anecdotal evidence and limited research suggesting TB-500 may support hair regrowth, likely through its effects on blood vessel formation and stem cell activation in hair follicles. However, hair regrowth is not a primary indication for TB-500. If hair loss is your primary concern, there are more targeted treatments. TB-500 is best used for tissue repair and recovery — any hair benefit would be a secondary effect.
References
- 1. Goldstein AL, et al. "Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues." Trends Mol Med. 2005;11(9):421-429.
- 2. Malinda KM, et al. "Thymosin beta4 accelerates wound healing." J Invest Dermatol. 1999;113(3):364-368.
- 3. Sosne G, et al. "Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury." Exp Eye Res. 2002;74(2):293-299.
- 4. RegeneRx Biopharmaceuticals. "Thymosin Beta 4 Clinical Development Program: Phase II Data for Chronic Wound Healing." 2010.
- 5. Bock-Marquette I, et al. "Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair." Nature. 2004;432(7016):466-472.
- 6. Goldstein AL, Goldstein AL. "From lab to bedside: emerging clinical applications of thymosin beta 4." Expert Opin Biol Ther. 2012;12(1):37-51.
- 7. Sosne G, et al. "Thymosin beta 4 and the eye: I can see clearly now the pain is gone." Ann N Y Acad Sci. 2010;1194:Thymosin Beta-4 Supplement, 1-6.
- 8. FDA. "Bulk Drug Substances Used in Compounding Under Section 503B of the FD&C Act." Federal Register, 2024.
INTERESTED IN TB-500?
We'll evaluate whether TB-500 is right for your condition, build a dosing protocol, and source it from a licensed compounding pharmacy.
Book Consultation